UKAD 2020 UKAD vs Andrew Lea

In April 2020 the United Kingdom Anti-Doping (UKAD) has reported an anti-doping rule violation against the rugby player Andrew Lea after his sample tested positive for the prohibited substances Drostanolone and Trenbolone. After notification the Athlete gave a prompt admission, waived his right for a hearing, accepted a provisional suspension and the sanction proposed by UKAD.

The Athlete stated that he had use the product TTM to improve his physical appearance and he was unaware that thist product contained steroids. He accepts that he was unable to demonstrate that his violation was not intentional.

Therefore UKAD decides on 22 September 2020 to impose a 4 year period of ineligibility on the Athlete starting on the date of sample collection, i.e. on 9 January 2020.

Original document

Parameters

Legal Source
National Decisions
Date
22 September 2020
Original Source
UK Anti-Doping (UKAD)
Country
United Kingdom
Language
English
ADRV
Adverse Analytical Finding / presence
Legal Terms
Acceptance of sanction
Prompt / Timely Admission
Waiver of "right to be heard"
Sport/IFs
Rugby (WR) - World Rugby
Other organisations
UK Anti-Doping (UKAD)
Laboratories
London, United Kingdom: Drug Control Centre
Doping classes
S1. Anabolic Agents
Substances
Drostanolone
Trenbolone (17β-hydroxyestr-4,9,11-trien-3-one)
Document type
Pdf file
Date generated
19 October 2020
Date of last modification
28 November 2020
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin